is compounded tirzepatide being discontinued Will Be Banned? Did the FDA Ban Compounded

These medications mimic the hormones in the body and can help to reduce food intake and increase insulin sensitivity

Tirzepatide 10 and 15 mg significantly reduced body weight versus semaglutide 2 mg with an ETD of 3.15 kg (95% CI 4.84, 1.46) and 5.15 kg (95% CI 6.85, 3.45), respectively

Additionally, the FDA grants statutory exclusivity periods that prevent generic competition regardless of patent status

Choosing the right syringe is part of choosing the right dose, and your tirzepatide dosage in units depends entirely on this precision

However, both medications have been shown to be safe and effective tools for weight management when used under medical supervision